Jill Kolesar, PharmD

Collaborating Principal Investigator
The University of Kentucky College of Pharmacy, United States

Presentation(s):

• P48: Preliminary Analysis of a Phase II Randomized Comparison of Flat vs Weight-based Mitomycin C Intraperitoneal Chemotherapy

  Thursday, March 21, 2024
  10:43am – 10:49am ET

• P36: Increased Efficacy of a Synergistic Combination in Sensitizing Pancreatic Neuroendocrine Tumors to Radiation in vivo

  Friday, March 22, 2024
  1:58pm – 2:04pm ET